The West China Medical Center, Sichuan University, formerly the West China University of Medical Sciences, is a prestigious world-class public research institution of medical sciences located in Chengdu, Sichuan, China.

During the past decade, West China Hospital，Sichuan University conducted 657 clinical trials. In the 10-year time frame, 657 clinical trials started and 82 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 394 clinical trials started and 65 clinical trials were completed. i.e. 16.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "West China Hospital，Sichuan University" #1 sponsor was "West China Hospital" with 70 trials, followed by "Hoffmann-La Roche" with 50 trials sponsored, "BeiGene" with 32 trials sponsored, "Eli Lilly and Company" with 29 trials sponsored and "Janssen Research & Development, LLC" with 29 trials sponsored. Other sponsors include 537 different institutions and companies that sponsored additional 253 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "West China Hospital，Sichuan University" #1 collaborator was "West China Hospital" with 30 trials as a collaborator, "LinkDoc Technology (Beijing) Co. Ltd." with 9 trials as a collaborator, "The First Hospital of Jilin University" with 9 trials as a collaborator, "First Affiliated Hospital of Xinjiang Medical University" with 7 trials as a collaborator and "First Affiliated Hospital, Sun Yat-Sen University" with 7 trials as a collaborator. Other collaborators include 680 different institutions and companies that were collaborators in the rest 457 trials.

According to Clinical.Site data, the most researched conditions in "West China Hospital，Sichuan University" are "Carcinoma, Non-Small-Cell Lung" (14 trials), "Advanced Solid Tumor" (13 trials), "Breast Cancer" (13 trials), "Non-small Cell Lung Cancer" (13 trials) and "Non-Small Cell Lung Cancer" (10 trials). Many other conditions were trialed in "West China Hospital，Sichuan University" in a lesser frequency.

Most popular intervention types in "West China Hospital，Sichuan University" are "Drug" (555 trials), "Procedure" (62 trials), "Device" (45 trials), "Other" (44 trials) and "Biological" (40 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (117 trials), "Tislelizumab" (17 trials), "Cisplatin" (15 trials), "Atezolizumab" (13 trials) and "Carboplatin" (12 trials). Other intervention names were less common.

The vast majority of trials in "West China Hospital，Sichuan University" are 712 trials for "All" genders, 20 trials for "Male" genders and 16 trials for "Female" genders.

Currently, there are 369 active trials in "West China Hospital，Sichuan University". 13 are not yet recruiting, 231 are recruiting, 116 are Active, not recruiting, and 9 are Enrolling by invitation. In total, there were 229 completed trials in West China Hospital，Sichuan University, 1 suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in West China Hospital，Sichuan University, 125 "Phase 1" clinical trials were conducted, 206 "Phase 2" clinical trials and 258 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 36 trials, and there were also 81 trials that are defined as “Not Applicable".